an小安2016-05-29 00:11
$Intercept Pharmaceuticals(ICPT)$
Intercept 的奥贝胆酸获批治疗原发性胆汁性肝硬化(PBC),近20年来首个获批的该类药物。虽然不是NASH适应症,但以获批一个小适应症开始,NASH皆有可能查看全文
an小安2016-04-05 23:13
$Intercept Pharmaceuticals(ICPT)$ intercept大涨,因为FDA外部专家组要讨论奥贝胆酸治疗原发性胆汁性肝硬化(PBC)数据。熊去氧胆酸目前是唯一获批用于 PBC 治疗的药物,但大多数患者的血清标志物碱性磷酸酶(ALP)继续持续性高,增加肝功能衰竭风险,这使得患者需要肝移植。这要是OCA在NASH(非...查看全文
淡投2016-02-23 06:59
M: $爱力根医疗(AGN)$
T: $Intercept Pharmaceuticals(ICPT)$
W: $RELYPSA(RLYP)$ $Sage Therapeutics(SAGE)$
T: $阿尔凯默斯(ALKS)$ $塞德斯医疗(CLDX)$ $Clovis Oncology(CLVS)$
F: $爱美医疗(FOLD)$查看全文
淡投2015-06-08 14:39
$Intercept Pharmaceuticals(ICPT)$
On June 2, Wedbush analyst Liana Moussatos published a list of upcoming catalysts for emerging pharmaceuticals, specifically for Intercept Pharmaceuticals Inc. (ICPT), Receptos Inc. (RCPT), and Omeros Corporation (OMER). Events such as ne...查看全文
淡投2015-05-20 08:52
$Intercept Pharmaceuticals(ICPT)$
Intercept (ICPT) NASH Study to be Larger, Riskier and Delayed, Leerink Partners Says
Leerink Partners analyst Joseph Schwartz weighed in on Intercept Pharmaceuticals (NASDAQ: ICPT) after the company announced the design of Ph.3 REGENE...查看全文
$Intercept制药(ICPT)$ 15-12G Securities registration termination [Section 12(g)] Accession Number: 0001104659-23-119815 Act: 34 Size: 12 KB 网页链接
$Intercept制药(ICPT)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-23-003317 Act: 33 Size: 1 KB 网页链接
$Intercept制药(ICPT)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-23-003316 Act: 33 Size: 1 KB 网页链接
$Intercept制药(ICPT)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-23-003320 Act: 33 Size: 1 KB 网页链接
$Intercept制药(ICPT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-23-117109 Size: 30 KB 网页链接
$Intercept制药(ICPT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-23-117105 Size: 21 KB 网页链接
$Intercept制药(ICPT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-23-117110 Size: 30 KB 网页链接
$Intercept制药(ICPT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-23-117112 Size: 26 KB 网页链接
$Intercept制药(ICPT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-23-117106 Size: 28 KB 网页链接
$Intercept制药(ICPT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-23-117117 Size: 34 KB 网页链接